anti-CMKLR1 antibody

Contáctenos para saber el precio
Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.
935106861
info@markelab.com
name
anti-CMKLR1 antibody
category
Primary Antibodies
provider
FineTest
reference
FNab10506
tested applications
ELISA, WB, IF
Documents del producto
Instrucciones
Data sheet
Product specifications
Category | Primary Antibodies |
Immunogen Target | Chemokine-like receptor 1 |
Host | Rabbit |
Reactivity | mouse,rat |
Recommended Dilution | WB: 1:500-1:2000; IF: 1:50-1:200 |
Clonality | polyclonal |
Conjugation | Unconjugated |
Isotype | IgG |
Observed MW | 55 kDa |
Purity | ≥95% as determined by SDS-PAGE |
Purification | Immunogen affinity purified |
Size 1 | 100µg |
Form | liquid |
Tested Applications | ELISA, WB, IF |
Storage | PBS with 0.02% sodium azide and 50% glycerol pH 7.3,-20℃ for 12 months(Avoid repeated freeze / thaw cycles.) |
UniProt ID | Q99788 |
Alias | CMKLR1,CHEMERINR,ChemR23,DEZ,ERV1,RVER1,chemokine receptor-like 1,Gpcr27,G-protein coupled receptor DEZ,resolvin E1 receptor,RVER1,tazarotene induced gene 2 receptor,TIG2 receptor |
Background | Antibody anti-CMKLR1 |
Status | RUO |
Note | This product is for research use only. |
(CMKLR1), also known as ChemR23, is a G-protein-coupled receptor (GPCR) primarily activated by chemerin, a protein involved in immune responses and adipose tissue regulation. CMKLR1 is expressed in immune cells, such as macrophages, dendritic cells, and natural killer (NK) cells, as well as in adipocytes and smooth muscle cells. Its signaling plays a crucial role in inflammation and immune cell migration, especially during tissue injury or infection. CMKLR1 activation promotes macrophage recruitment to inflamed tissues, aiding in immune responses and wound healing. It also influences adipogenesis and metabolic regulation, contributing to energy balance and insulin sensitivity. CMKLR1 is implicated in cardiovascular diseases, where it regulates vascular inflammation and smooth muscle contraction, affecting blood pressure and vessel remodeling. Dysregulation of CMKLR1 signaling has been linked to metabolic disorders such as obesity, type 2 diabetes, and chronic inflammation. Moreover, CMKLR1 is being investigated as a target in autoimmune diseases and cancers, where its modulation could impact tumor microenvironments and immune evasion. The receptor's dual role in metabolic homeostasis and immune regulation positions it as a potential target for novel therapeutic interventions.
Related Products

anti-CMKLR1 antibody
Ver Producto
Chemokine Like Receptor 1 (CMKLR1) Antibody
Rabbit polyclonal antibody against CMKLR1 protein. Immunogen region is Internal.
Ver Producto
Chemokine Like Receptor 1 (CMKLR1) Antibody
Orphan receptor. Could be a chemotactic peptide receptor. May have a function in bone metabolism. Acts as a coreceptor for several SIV strains (SIVMAC316, SIVMAC239, SIVMACL7E-FR and SIVSM62A), as well as a primary HIV-1 strain (92UG024-2).
Ver Producto